Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $90.1463 (0.62%) ($89.7206 - $90.7559) on Mon. Apr. 23, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.11% (three month average) | RSI | 63 | Latest Price | $90.1463(0.62%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 0.1% a day on average for past five trading days. | Weekly Trend | ABBV advances 1.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(61%) VYM(50%) IVE(48%) SPLV(48%) IWD(47%) | Factors Impacting ABBV price | ABBV will decline at least -1.555% in a week (0% probabilities). VIXM(-15%) TLT(-14%) UUP(-11%) DIA(-8%) DRIV(-6%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.555% (StdDev 3.11%) | Hourly BBV | 0 () | Intraday Trend | 0.3% | | | |
|
5 Day Moving Average | $90.31(-0.18%) | 10 Day Moving Average | $89.86(0.32%) | 20 Day Moving Average | $89.17(1.09%) | To recent high | -23.6% | To recent low | 4.9% | Market Cap | $159.044b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |